Amul S Bahl, a well-known Vedanta practitioner, is a seamless blend of contemporary science and traditional Vedic philosophy. Amul, who holds an M.Tech. from the esteemed Indian Institute of Technology in Delhi, has always been an innovator.
From a young age, he excelled in school and had a sympathetic personality who felt other people's suffering and was constantly willing to offer support. Amul is a heterogeneous mix of humility, empathy, selflessness, and genuine love for one's country and fellow citizens, together with mental prowess, a scientific bent, and life-changing discoveries. But in reality, he still maintains a straightforward, unassuming persona.
Amul is renowned for introducing Ayurvedic Nanocellopathy as a healthcare technology for society through his venture ‘Yogic Naturals’. A technique that leverages the synergies of several plant extracts and their therapeutic algorithms was developed after 27 years of research.
Amul’s Yogic Naturals began as a little Seva in the 1990s, while he was still pursuing his M. Tech. at the Indian Institute of Technology (IIT) of Delhi. Having carved its own niche, today Yogic Naturals is the pioneering company in the world that can treator manage internal problems and manage them by topically applying a few drops of oil serum. This also has clinical validation backing.
First and foremost, being of a scientific bent of mind, Amul has devoted significant energy and effort to validate and document the efficacy of Yogic Naturals Products. Yogic Naturals has conducted numerous double-blind placebo/medication controlled clinical studies that have been carried out by an independent Clinical Research Organization headed by an MD from AIIMS, in line with his philosophy of scientifically validating traditional knowledge. The trials are registered under Clinical Trial Registry of India and adhered to worldwide GCP standards.
The research hasalso been published in reputable international peer-reviewed medical journals. This has been significant because only a select few Ayurvedic products go through such scientific and safety validation while also being acknowledged by practitioners of contemporary medicine.Under his leadership, Yogic Naturals products have so far been the subject of eight CTRI-registered human clinical trials, published in nine publications in peer-reviewed international medical journals, and many patent applications are underway.
Significantly, its innovation produced the path-breaking research on COVID-19- atopically used treatment and lung repair solution, researched in collaboration with AIIMS Delhi and now part of WHO Research Database for COVID. Being of critical importance in tackling COVID and associated Lung Damage, this Research is also available on Pub Med, Elsevier amongst others.
